IA
MRNA icon

IndexIQ Advisors’s Moderna MRNA Stock Holding History

IndexIQ Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.05M Buy
6,076
+298
+5% +$50.2K 0.04% 272
2021
Q4 		$1.47M Sell
5,778
-167
-3% -$48.8K 0.05% 251
2021
Q3 		$2.29M Buy
5,945
+330
+6% +$122K 0.08% 226
2021
Q2 		$1.32M Buy
5,615
+412
+8% +$73.6K 0.04% 257
2021
Q1 		$681K Buy
5,203
+681
+15% +$98.7K 0.02% 317
2020
Q4 		$472K Buy
+4,522
New +$457K 0.02% 414

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

IndexIQ Advisors's MRNA Position: Q1 2022 in Review

IndexIQ Advisors increased its Moderna (MRNA) stake by 5.2% in Q1 2022, buying an estimated $50.2K and bringing the position to 6,076 shares worth $1.05M. The position accounts for 0.04% of the portfolio, ranked #272.

IndexIQ Advisors first reported a position in MRNA in Q4 2020 and has held it in 6 quarters since. The position peaked at $2.29M in Q3 2021. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • IndexIQ Advisors held 6,076 shares of Moderna worth $1.05M as of Q1 2022.
  • IndexIQ Advisors bought 298 Moderna shares in Q1 2022, an estimated $50.2K.
  • Moderna made up 0.04% of IndexIQ Advisors's portfolio in Q1 2022, its #272 holding.
  • IndexIQ Advisors first reported a position in Moderna in Q4 2020 and has held it in 6 quarters since.
  • IndexIQ Advisors's Moderna position peaked at $2.29M in Q3 2021.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.